STAA News and Press, STAAR Surgical Company From 12/15/25

STAAR Urges Stockholders to Vote “FOR” Alcon Merger on the WHITE Proxy Card TODAY STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision co...

2025-12-12 15:00:05 ET More on the markets S&P 500's Outlook For 2026: Don't Expect This Rally To Fade 2026 Market Outlook: A Grinding Bull Market In A Frothy S&P 500 AI Is The Last Defense Against Stagflation: Why Tech And Energy Will Lead In 2026 Ma...

2025-12-12 11:24:03 ET More on STAAR Surgical, Alcon STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain Alcon: Some Premium Coming Out Of This Quality Play Alcon Inc. (ALC) Q3 2025 Earnings Call Transcript Alcon draws double downgrade at BofA on earni...

Contends STAAR’s Process Was Ineffective in Establishing Competitive Auction and Securing Maximum Value for Shareholders Argues Board’s Procedural Credibility Is “Remarkably Threadbare” Broadwood Continues to Urge Shareholders to Vote “ ...

Activist Investors Have Twisted Facts Regarding STAAR’s Engagement with a Potentially Interested Party During Go-Shop Process The Potentially Interested Party Reached Out on Day 21 of 30-Day Go-Shop Process and Refused to Sign an NDA Even without a Standstill Broadwood Part...

Encouraged that at Least One Member of STAAR’s Board Recognizes the Flaws of the Sale Process and that the Go-Shop Process was Performative Questions Completeness of Disclosures Given Critical Omission of Inbound Interest from Respected Private Equity Firm that Indicated It Would P...

2025-12-10 10:08:45 ET More on STAAR Surgical STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain STAAR Surgical jumps after Alcon raises offer to $30.75/share in cash (update) STAAR Surgical says no offers received during go-shop period Seeking Alpha&...

2025-12-10 07:30:01 ET STAAR Surgical ( STAA ) received an acquisition offer from Alcon Inc. ( ALC ) in August for $28 per share, which represented over a 50% premium to the prior share price. In my writeup covering this, I concluded that the offer provided STAA's shareh...

Believes STAAR’s Sale Process Was Structured to Seal the Alcon Deal, Not to Maximize Value for Shareholders The Company Is Not Ripe for Sale at This Time Continues to Urge STAAR Shareholders to Vote “ AGAINST ” the Proposed Transaction Yunq...

Notes That Price Bump Is Further Evidence That the Original Sale Process Was Horribly Flawed and Failed to Maximize Shareholder Value New Price Is Approximately Half the Price Offered by Alcon Twice in 2024; STAAR’s Projections Have Not Changed Materially Continues to Urge ...